Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II study
G. Bolis, S. Danese, S. Tateo, E. Rabaiotti, G. D'Agostino, C. Merisio, G. Scarfone, G. Polverino, F. Parazzini
International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 74-78; DOI: 10.1136/ijgc-00009577-200602001-00012
